logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
F

Francesco Passamonti

University of Milan

90H-index
699Paper Count
3.9WCitation Count
Published Papers 193
Publication Date
logo
Adding transcriptomic features to MF prognostic models
errBlood
IF23.1
err2026-05-07
err0
PREAI
errFrancesco Passamonti
errShare
errSave
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study
errBlood Advances
IF7.1
err2026-05-02
err0
errOAAI
errHarinder Gill; Abdulraheem Yacoub; Aaron T. Gerds; Jake Shortt; James M. Rossetti; Adam J. Mead; Joachim R Göthert; Steffen Koschmieder; Joanne Ewing; Anna Halpern; Francesca Palandri; Francesco Passamonti; Ruben Mesa; Monia Marchetti; Claire Harrison; Alessandro M. Vannucchi; Justin M. Watts; John C. Wood; David M. Ross; Jennifer Peppe
errShare
errSave
Identification of ceRNA Regulatory Networks Driven by the lncRNA NEAT1 in Multiple Myeloma
errJournal of Cellular and Molecular Medicine
IF4.2
err2026-04-02
err0
errOAAI
errDomenica Ronchetti; Valentina Traini; Ilaria Silvestris; Giuseppina Fabbiano; Andrea Devecchi; Federica Torricelli; Noemi Puccio; Ilaria Craparotta; Marco Bolis; Roberto Piva; Antonino Neri; Luca Agnelli; Francesco Passamonti; Niccolò Bolli; Elisa Taiana
errShare
errSave
Health Care Utilization Databases obtained from health system inform outcome for ruxolitinib treatment in patients with myelofibrosis
errHemaSphere
IF14.6
err2026-02-24
err0
errOAAI
errBarbara Mora; Matteo Franchi; Ludovica Margotto; Olivia Leoni; Daniela D'ippoliti; Emanuela Carloni; Ilaria Cozzi; Enrica Santelli; Fabrizio Gemmi; Claudia Szasz; Margherita Maffioli; Carmelo Gurnari; Enrico Attardi; Daniele Cattaneo; Marta Bortolotti; Nicola Stefano Fracchiolla; Alessandra Iurlo; Giovanni Corrao; Matteo Giovanni Della Porta; Alessandro Maria Vannucchi; Maria Teresa Voso; Paola Guglielmelli; Francesco Passamonti
errShare
errSave
Characterization of a Newly Discovered Non-Coding Variant in the EPO Gene Identified in Two Unrelated Italian Pedigrees With Erythrocytosis
errAmerican Journal of Hematology
IF9.9
err2026-02-18
err0
errOAAI
errBarbara Mora; Valentina Bellani; Daniela Pietra; Elena Tagliaferri; Daniele Cattaneo; Oscar Borsani; Alessandra Iurlo; Elisa Fermo; Paola Bianchi; Elisa Rumi; Francesco Passamonti
errShare
errSave
Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic options
errHEMASPHERE
IF14.6
err2025-12-09
err0
errOAAI
errIurlo, Alessandra; Cattaneo, Daniele; Gianelli, Umberto; Passamonti, Francesco
errShare
errSave
Predicting the differential diagnosis of inherited versus acquired bone marrow failure syndromes: Development of simple clinical scoring systems
errBRITISH JOURNAL OF HAEMATOLOGY
IF3.8
err2025-12-01
err0
PREAI
errBortolotti, Marta; Fattizzo, Bruno; Stella, Simona; Jiang, Jie; Versino, Francesco; Engelbrecht, Clair; Trikha, Roochi; Large, Joanna; Gandhi, Shreyans; Snape, Katie; Consonni, Dario; Passamonti, Francesco; Barcellini, Wilma; Kulasekararaj, Austin G.
errShare
errSave
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis
errBlood Cancer Journal
IF11.6
err2025-11-24
err0
errOAAI
errMonia Marchetti; Alessandro Maria Vannucchi; John O. Mascarenhas; Alberto Alvarez-Larran; Prithviraj Bose; Robert Peter Gale; Claire Harrison; Rűdiger Hehlmann; Jean-Jacques Kiladjian; Steffen Koschmieder; Ruben Mesa; Francesco Passamonti; Alessandro Rambaldi; Ayalew Tefferi; Tiziano Barbui
errShare
errSave
Effect of obexelimab on the production of anti-RBC antibodies and cytokines in patients with warm autoimmune hemolytic anemia
errBlood Advances
IF7.1
err2025-10-10
err0
errOAAI
errBruno Fattizzo; Anna Zaninoni; Giacinto Luca Pedone; Marta Bortolotti; Francesco Passamonti; Wilma Barcellini
errShare
errSave
Viral respiratory infections in patients with hematological diseases over 10 years: epidemiology and impact on disease severity
errDIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
IF1.8
err2025-10-01
err0
PREAI
errBono, Patrizia; Parisi, Alessandra; Tagliaferri, Elena; Ungaro, Riccardo; Saporiti, Gorgia; Cavallaro, Francesca; Bozzi, Giorgio; Goldaniga, Maria Cecilia; Galli, Gianluigi; Hejazifar, Niloofar; Allaria, Silvia; Biassoni, Caterina; Giacomel, Giovanni; Valzano, Antonia; Sciume, Mariarita; Fracchiolla, Nicola; Bandera, Alessandra; Passamonti, Francesco; Callegaro, Annapaola; Alteri, Claudia
errShare
errSave
Treatment persistence and overall survival in myelofibrosis treated with ruxolitinib were not affected by the covid-19 pandemic, despite the reduced starting dose: Analysis of AIFA registries
errAnnals of Hematology
IF2.4
err2025-09-20
err0
errOAAI
errMassimo Breccia; Simone Celant; Francesca Palandri; Francesco Passamonti; Pier Paolo Olimpieri; Valentina Summa; Annalisa Guarcello; Giuseppe Alberto Palumbo; Fabrizio Pane; Paola Guglielmelli; Pierluigi Zinzani; Paolo Corradini; Pierluigi Russo
errShare
errSave
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing
errSignal Transduction and Targeted Therapy
IF52.7
err2025-08-25
err0
errOAAI
errBruno Fattizzo; Matteo Claudio Da Vià; Francesca Lazzaroni; Alfredo Marchetti; Alessio Marella; Akihiro Maeda; Antonio Giovanni Solimando; Loredana Pettine; Francesco Passamonti; Niccolò Bolli; Wilma Barcellini
errShare
errSave
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience
errAmerican Journal of Hematology
IF9.9
err2025-08-11
err0
errOAAI
errBruno Fattizzo; Giacinto Luca Pedone; Elisabetta Metafuni; Eloise Beggiato; Valentina Giai; Esther Natalie Oliva; Antony Ricchiuti; Marta Bortolotti; Simona Raso; Daniela Carlino; Mara Memoli; Sofia Vecchi; Jennifer Vidler; Sukanya Gogoi; Shreya Goel; Anna Corby; Roochi Trikha; Sneha Balakrishnan; Francesco Passamonti; Anna Paola Iori; Simona Sica; Shreyans Gandhi; Wilma Barcellini; Austin Kulasekararaj
errShare
errSave
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design
errAnnals of Hematology
IF2.4
err2025-07-18
err0
errOAAI
errValerio De Stefano; Francesco Passamonti; Francesca Palandri; Francesco Ramundo; Elena Rossi; Silvia Betti; Lorenzo Fagiolo; Paola Guglielmelli; Davide Pio Abagnale; Novella Pugliese; Daniele Cattaneo; Alessandra Iurlo; Filippo Branzanti; Alessandra Dedola; Hillary Catellani; Alessia Tieghi; Marco Basso; Elisabetta Calistri; Elena Maria Elli; Elena Masselli; Erika Morsia; Giulia Benevolo; Massimo Breccia; Vincenza de Fazio; Maria Di Perna; Monia Marchetti; Marco Santoro; Agostino Tafuri; Chiara Castiglioni; Chiara Rotella; Sergio Siragusa; Alessandro Maria Vannucchi
errShare
errSave
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study
errTherapeutic Advances in Hematology
IF3.1
err2025-07-04
err0
errOAAI
errSteffen Koschmieder; Clemens Schulte; Eyck von der Heyde; Lambert Busque; Françoise Boyer-Perrard; Timothy Devos; Francesco Passamonti; Wendy Y. Cheng; Mu Cheng; Marja Nuortti; Volker Baum; Claire Harrison
errShare
errSave
Rituximab efficacy for minimal residual disease eradication in philadelphia-negative acute lymphoblastic leukemia CD20+
errANNALS OF HEMATOLOGY
IF2.4
err2025-05-16
err0
errOAAI
errCecchi, Nicola; Sciume, Mariarita; Ricchiuti, Antony; Bosi, Alessandro; Tagliaferri, Elena; Passamonti, Francesco; Fracchiolla, Nicola Stefano
errShare
errSave
BLAST: a globally applicable and molecularly versatile survival model for chronic myelomonocytic leukemia
errBlood
IF23.1
err2025-05-09
err0
PREAI
errAyalew Tefferi; Saubia Fathima; Maymona Abdelmagid; Ali Khalid A. Alsugair; Fnu Aperna; Mahsa Rezasoltani; Muhammad Yousuf; Anuya Natu; Clifford M. Csizmar; Mark Gurney; Terra L. Lasho; Christy M. Finke; Rashmi Kangal-Shamanna; Danielle Hammond; Kelly Chien; Alexandre Bazinet; Courtney D. DiNardo; Tapan M. Kadia; Abhishek A. Mangaonkar; Naval Daver; Animesh Pardanani; Gautam Borthakur; Cinthya Zepeda-Mendoza; Kaaren K. Reichard; Rong He; Sanam Loghavi; Francesco Passamonti; Farhad Ravandi; Koji Sasaki; Dirk R. Larson; Guillermo Garcia-Manero; Francesco Onida; Naseema Gangat; Guillermo Montalban-Bravo; Mrinal M. Patnaik
errShare
errSave
Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinib
errFUTURE ONCOLOGY
IF2.6
err2025-01-26
err0
errOAAI
errPassamonti, Francesco; Korgaonkar, Siddhi; Parikh, Rohan C.; Chevli, Manoj; Yucel, Aylin; Rombi, Julien; Jones, Shalon; Zissler, Dorothy; Davis, Keith L.; Slaff, Samantha
errShare
errSave
POIESIS: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Phase 3 Study of Navtemadlin As Add-on to Ruxolitinib in JAK Inhibitor-Naive Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errVachhani, Pankit; Rampal, Raajit; Bradley, Terrence; Harrison, Claire; Jain, Tania; Kuykendall, Andrew T.; Palandri, Francesca; Mascarenhas, John O.; Al-Ali, Haifa Kathrin; Passamonti, Francesco; Nekhymchuk, Anna; Foss, Hilarie; Rothbaum, Wayne; Verstovsek, Srdan; Heidel, Florian
errShare
errSave
A Phase 1/2 Study of Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor, in Combination with JAK Inhibitors Ruxolitinib or Momelotinib in Patients with Myelofibrosis
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errMascarenhas, John O.; Rampal, Raajit; El Chaer, Firas; Gupta, Vikas; Shimoda, Kazuya; Kiladjian, Jean-Jacques; Passamonti, Francesco; Bose, Prithviraj; Scandura, Joseph M.; Mesa, Ruben; Rein, Lindsay A. M.; Yuda, Junichiro; Ross, David M.; Devos, Timothy; Talpaz, Moshe; Hoffman, Ronald; Kabir, Sujan; Li, Zhonggai; Foulks, Jason M.; Ansaldo, Karen; Seki, Masataka; Peddagali, Vishnu; Shah, Jatin; Harrison, Claire
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
H
Hagop M. Kantarjian
H-index: 230 · Papers: 5.5K
E
Elı́as Campo
H-index: 173 · Papers: 1.6K
A
Ayalew Tefferi
H-index: 152 · Papers: 2.1K
P
Pierre Fenaux
H-index: 130 · Papers: 1.8K
A
Andreas Hochhaus
H-index: 127 · Papers: 1.6K
View more